Immunological characterization of urinary 8-epi-prostaglandin F2 alpha excretion in man.
about
Long-term vitamin E supplementation fails to reduce lipid peroxidation in people at cardiovascular risk: analysis of underlying factors.Oxidative stress in the aging rat heart is reversed by dietary supplementation with (R)-(alpha)-lipoic acidOxidative lipidomics coming of age: advances in analysis of oxidized phospholipids in physiology and pathologyNOX2-generated oxidative stress is associated with severity of ultrasound liver steatosis in patients with non-alcoholic fatty liver disease.Mitochondrial DNA sequence associations with dementia and amyloid-β in elderly African AmericansMeasurement of isoprostanes as markers of oxidative stress in neuronal tissue.Urinary 15-F2t-isoprostane, aflatoxin B1 exposure and hepatitis B virus infection and hepatocellular carcinoma in Taiwan.Rapid quantitative analysis of 8-iso-prostaglandin-F(2alpha) using liquid chromatography-tandem mass spectrometry and comparison with an enzyme immunoassay method.Oxidative stress mediated arterial dysfunction in patients with obstructive sleep apnoea and the effect of continuous positive airway pressure treatment.F2-isoprostanes as an indicator and risk factor for coronary heart disease.Lipid peroxidation and depressed mood in community-dwelling older men and women.Effect of common single nucleotide polymorphisms in COX-1 gene on related metabolic activity in diabetic patients treated with acetylsalicylic acidDifferent degrees of NADPH oxidase 2 regulation and in vivo platelet activation: lesson from chronic granulomatous diseaseCirculating myeloid-related protein-8/14 is related to thromboxane-dependent platelet activation in patients with acute coronary syndrome, with and without ongoing low-dose aspirin treatment.Exhaled 8-isoprostane as a new non-invasive biomarker of oxidative stress in cystic fibrosis.Effect of α-lipoic acid on platelet reactivity in type 1 diabetic patientsInduction of prostaglandin endoperoxide synthase-2 in human monocytes associated with cyclo-oxygenase-dependent F2-isoprostane formation.Oxidative damage, platelet activation, and inflammation to predict mobility disability and mortality in older persons: results from the health aging and body composition study.IPF2alpha-I: an index of lipid peroxidation in humansQuantitative high performance liquid chromatography/tandem mass spectrometric analysis of the four classes of F(2)-isoprostanes in human urineEnhanced lipid peroxidation and platelet activation as potential contributors to increased cardiovascular risk in the low-HDL phenotypePlasma Carotenoids and Biomarkers of Oxidative Stress in Patients with prior Head and Neck Cancer.Oestrogen metabolites in relation to isoprostanes as a measure of oxidative stressDietary fat subgroups, zinc, and vegetable components are related to urine F2a-isoprostane concentration, a measure of oxidative stress, in midlife women.Localization of distinct F2-isoprostanes in human atherosclerotic lesions.Moderate weight loss decreases oxidative stress and increases antioxidant status in patients with metabolic syndrome.Serum Cytokeratin-18 Is Associated with NOX2-Generated Oxidative Stress in Patients with Nonalcoholic Fatty Liver.Effect of Cruciferous Vegetable Intake on Oxidative Stress Biomarkers: Differences by Breast Cancer Status.Synthesis of 8-epi-prostaglandin F2alpha by human endothelial cells: role of prostaglandin H2 synthase.The enigma of in vivo oxidative stress assessment: isoprostanes as an emerging target.Toxicological profile of chlorophenols and their derivatives in the environment: the public health perspective.Breathomics for Assessing the Effects of Treatment and Withdrawal With Inhaled Beclomethasone/Formoterol in Patients With COPD.Metabolomic Analysis by Nuclear Magnetic Resonance Spectroscopy as a New Approach to Understanding Inflammation and Monitoring of Pharmacological Therapy in Children and Young Adults With Cystic Fibrosis.
P2860
Q24794281-0C79D478-0D22-40DE-9F7B-B2B3455F2A11Q28361014-F1729424-B83C-4F6E-9638-80D1B553E921Q28397441-036433DD-81D7-46E8-A4FF-F875E1E52F02Q33583595-BF121D5F-CE66-4C43-BD85-7CADA824775BQ33603868-9A898E14-4AE2-4CD4-92DC-C37DA42B98DAQ33688993-E1540DD0-5458-43B3-B186-46C1AB6A2095Q33986238-5FB175D8-14C8-4A3E-B6A3-13D7CBD06F29Q34018593-7187198F-9D76-4C9E-813B-832B276A5884Q34348192-C0D52887-C762-4D52-8682-A67301B9B074Q34684200-A7E504A8-AD5E-4FDC-8D11-DB19ADF5A2F2Q34775703-01CE25B4-765F-4702-B8AD-625A9E6D1F26Q34974280-08C6A415-6BE2-499D-9CDD-83D32ADF4A41Q35021974-9C7D86A3-3497-43B5-8BBE-A66A3B98A155Q35026251-85F49D47-C4B7-4DEB-A928-EAE1CFB92C33Q35533667-8E6116EC-3884-4B58-BF31-0AA43207BBD0Q35688268-58854AA1-DC55-401F-8EBF-420570A5417DQ35873648-BD188B67-0CD4-4B42-9FAE-2B87F20D504DQ35947427-301497DD-6A44-4130-A2EB-3B19689A95D1Q36001536-646AA320-913C-46E4-99E0-F7B6BC9FB1E6Q36674399-C10FB462-8436-4EF4-84B1-1AC29066CD5DQ36824819-A0AD0537-0085-4757-A172-059B2B373ED1Q37238388-060D829A-31DF-4BE2-95BF-D0EC46EBE205Q37307074-04DBB600-F33D-4C22-BE15-063BB22ECB14Q37314580-3BA69E68-5A93-4630-A885-52A6671AC920Q37373646-D3031BC7-72C8-4157-A216-4C18115D0D2AQ37556294-D35AB1A2-16EF-4C19-8828-C47F4690DF47Q37616138-8B52BADD-A13F-4E7B-ADB3-1D3546843D7CQ40302664-D45C335D-55F9-40C9-98FC-B19C53F186E1Q40913495-3A9E3A23-CF10-4500-924A-05D817A4AFACQ45904642-D419F902-3B88-463D-A536-AE79DED400B5Q52756288-06664C7F-0164-47E9-8EC8-82C46381278FQ55202240-7FDA5CEC-7F88-4CEC-92B4-4EF3D94D2F2DQ55410086-E833BA4F-C34D-47BF-8C11-E774A4CC9DA3
P2860
Immunological characterization of urinary 8-epi-prostaglandin F2 alpha excretion in man.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Immunological characterization of urinary 8-epi-prostaglandin F2 alpha excretion in man.
@en
Immunological characterization of urinary 8-epi-prostaglandin F2 alpha excretion in man.
@nl
type
label
Immunological characterization of urinary 8-epi-prostaglandin F2 alpha excretion in man.
@en
Immunological characterization of urinary 8-epi-prostaglandin F2 alpha excretion in man.
@nl
prefLabel
Immunological characterization of urinary 8-epi-prostaglandin F2 alpha excretion in man.
@en
Immunological characterization of urinary 8-epi-prostaglandin F2 alpha excretion in man.
@nl
P2093
P1476
Immunological characterization of urinary 8-epi-prostaglandin F2 alpha excretion in man.
@en
P1933
P2093
Ciabattoni G
Créminon C
Fitzgerald GA
P304
P407
P577
1995-10-01T00:00:00Z